Lakefront Biotherapeutics (LKFT) Interest & Investment Income (2018 - 2025)

Lakefront Biotherapeutics (LKFT) reported Interest & Investment Income of -$24.7 million for Q2 2025, up 53.65% year-over-year from -$16.1 million in Q2 2024, and up 53.65% quarter-over-quarter from -$53.2 million in Q2 2024.

Lakefront Biotherapeutics (LKFT) Interest & Investment Income (2018 - 2025) Analysis & Trends

Lakefront Biotherapeutics (LKFT) has 5 years of Interest & Investment Income data on file, last reported at -$24.7 million in Q2 2025.

  • Interest & Investment Income for Q2 2025 came in at -$24.7 million, up 53.65% year-over-year; the trailing twelve-month figure through Jun 2025 was -$24.7 million (up 53.65% YoY), and the FY2025 annual result was $53.9 million, down 43.52% from the prior year.
  • Interest & Investment Income grew to -$24.7 million in Q2 2025 per LKFT's latest filing, from -$53.2 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at -$24.7 million in Q2 2025 and troughed at -$53.2 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 597,319.59
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 305,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 114.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - -14.79 Mn
10 Lakefront Biotherapeutics 9.64 Bn 9.64 Bn 1.97 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -24.67 Mn
Jun 30, 2024 -53.22 Mn
Mar 31, 2020 -2.31 Mn
Sep 30, 2019 -8.27 Mn
Mar 31, 2019 -2.07 Mn
Sep 30, 2018 -3.63 Mn
Mar 31, 2018 -982,826.23